ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $49,000 | +4.3% | 25,748 | +3.6% | 0.00% | – |
| Q3 2015 | $47,000 | -67.4% | 24,848 | -20.2% | 0.00% | -100.0% |
| Q2 2015 | $144,000 | -87.7% | 31,140 | -88.3% | 0.00% | -91.7% |
| Q1 2015 | $1,166,000 | +50.1% | 266,900 | +19.3% | 0.01% | +140.0% |
| Q4 2014 | $777,000 | +20.7% | 223,804 | +45.7% | 0.01% | +66.7% |
| Q3 2014 | $644,000 | -12.3% | 153,600 | +22.7% | 0.00% | 0.0% |
| Q2 2014 | $734,000 | -76.9% | 125,164 | -75.1% | 0.00% | -82.4% |
| Q1 2014 | $3,171,000 | +64.0% | 503,264 | +52.3% | 0.02% | +70.0% |
| Q4 2013 | $1,933,000 | +279.8% | 330,503 | +242.6% | 0.01% | +233.3% |
| Q3 2013 | $509,000 | -68.0% | 96,480 | -53.3% | 0.00% | -70.0% |
| Q2 2013 | $1,592,000 | – | 206,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |